05:26 PM EDT, 08/15/2024 (MT Newswires) -- Gary A Lyons, Director, on August 13, 2024, sold 11,570 shares in Neurocrine Biosciences ( NBIX ) for $1,740,450. Following the Form 4 filing with the SEC, Lyons has control over a total of 119,047 shares of the company, with 119,047 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447524000195/xslF345X03/wk-form4_1723756911.xml